查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1929634

半月軟骨修復錨釘市場按類型、材料、應用和最終用戶分類，全球預測（2026-2032年）

Meniscus Repair Anchor Market by Type, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年半月軟骨修復錨釘市場價值為 5.5812 億美元，預計到 2026 年將成長至 6.0316 億美元，到 2032 年預計將達到 9.1637 億美元，複合年成長率為 7.34%。

主要市場統計數據
基準年 2025 5.5812億美元
預計年份：2026年 6.0316億美元
預測年份：2032年 9.1637億美元
複合年成長率 (%) 7.34%

探討臨床優先事項、手術效率和商業性壓力如何重塑半月軟骨修復錨釘的研發和應用。

半月軟骨修復錨釘市場正經歷著一個以臨床證據、不斷發展的外科技術和醫療服務管道變革為驅動力的穩健創新階段。旨在恢復膝關節穩定性和功能的器械，其評估標準不僅包括固定強度和生物相容性，還包括與關節鏡流程的整合、器械的人體工學設計以及與注重成本效益的醫療路徑的兼容性。外科醫生和採購相關人員優先考慮的是那些能夠提供可靠臨床療效，同時又能簡化手術室時間和庫存管理的解決方案。

臨床進展、材料創新和以價值為導向的醫療保健服務如何融合，從而改變半月軟骨修復錨定策略和市場動態

近年來，臨床實踐、材料科學和醫療服務領域發生了變革性變化，重塑了半月軟骨修復錨釘的模式。隨著訓練項目和醫療設備研發人員不斷降低術中複雜性，微創關節鏡手術技術持續發展，能夠更精準地修復複雜的斷裂模式，並擴大適應症。錨釘形狀和輸送系統的同步進步提高了操作靈活性，而生物可吸收聚合物的改進則增強了外科醫生的信心，使他們相信無需永久性金屬部件即可實現長期的組織整合。

評估2025年關稅主導的供應鏈變化和貿易政策調整對醫療設備價值鏈採購行為、籌資策略和成本壓力的影響

近期政策週期中關稅的徵收和貿易政策的動態對醫療設備的採購、零件供應和定價產生了連鎖反應，為2025年後的戰略規劃奠定了關鍵基礎。影響原料、成品和中間零件的關稅增加了許多醫療設備製造商的到岸成本，迫使他們重新審視供應商契約，考慮其他採購地區，並與機構買家進行價格談判。這些成本壓力促使採購團隊更密切地關注總體擁有成本，包括器械耐用性、再次手術率以及影響治療經濟效益的營運效率。

詳細的細分分析揭示了設備類型、材料選擇、臨床方法和最終用戶環境如何相互作用，從而塑造採用模式和商業性定位。

分析揭示了不同器械類型、材料、臨床適應症和臨床環境的採用和發展軌跡。對全內入路、由內向外入路、由外向內入路和膝蓋骨修復技術的分析表明，針對微創關節關節鏡流程最佳化的器械在視野清晰和軟組織處理至關重要的領域越來越受到臨床醫生的青睞。在手術量大的環境中，能夠減少打結、簡化器械操作和縮短手術時間的設計選擇尤其受到重視。

區域比較分析解釋了臨床實踐、報銷複雜性和供應鏈因素如何影響全球市場的產品採用。

區域趨勢顯示，臨床實務模式、報銷架構和供應鏈物流存在顯著差異，這些差異會影響產品策略和商業化計畫。在美洲，醫療機構對微創技術的廣泛應用以及集中化的門診護理中心網路，為那些展現出顯著手術效率和永續治療效果的醫療器械創造了廣闊的市場機會。該地區的支付方談判和醫院採購流程均強調，比較臨床證據和生命週期成本是決定產品採納的關鍵因素。

決定市場定位的關鍵競爭動態和公司層面策略：產品設計、臨床證據和供應鏈韌性

半月軟骨固定器械領域的競爭格局由成熟的整形外科公司和靈活的專業器械製造商組成，後者透過材料科學、器械設計和外科醫生培訓計畫來脫穎而出。成熟的製造商往往利用廣泛的分銷網路和豐富的臨床證據來維持其在醫院系統和大型採購集團中的優先供應權。而小規模的創新者則傾向於透過新穎的輸送機制、簡化的手術流程以及展現特定領域優勢的針對性臨床數據來展開競爭。

為製造商和醫療服務提供者領導者提供如何協調臨床證據、價值鏈策略和商業模式以實現持續應用和價值交付的實用建議

產業領導者應採取將產品創新與實證醫學、供應鏈穩健性和客製化商業模式結合的方法。優先投資於臨床研究和註冊登記，將錨定選擇與以患者為中心的有意義的療效和手術效率聯繫起來，從而促進採購方和支付方之間超越單價比較的對話。同時，最佳化手術器械，減少操作步驟，並鼓勵那些追求速度和精準度的外科醫生採用這些器械。

本分析所依據的調查方法將以透明的方式進行解釋，採用混合方法，結合臨床醫師訪談、文獻綜合和相關人員檢驗檢驗研究結果。

本分析的研究結合了定性訪談、文獻綜述以及對臨床和採購趨勢的系統性綜合分析，建構了一個連貫的證據體系。主要數據包括與骨科醫生、門診和住院採購經理以及醫療設備研發專家的結構化訪談，旨在收集真實世界的案例、推廣障礙和臨床偏好。次要資訊則來自同儕審查的臨床研究、監管指南和公共衛生政策文件，以支持對臨床性能和安全性的考慮。

結論部分概述了以證據為導向的產品設計、協作和穩健的供應鏈策略如何決定產品的長期應用和商業性成功。

分析結論認為，半月軟骨修復錨釘領域的持續商業性成功將有利於那些將成熟的臨床性能與實際考慮（例如手術效率、供應鏈韌性以及滿足終端用戶操作需求）相結合的解決方案。優先考慮錨釘選擇能夠改善患者預後並減輕手術負擔的證據的器械製造商，將更有利於吸引注重性價比的買家並抵禦價格壓力。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

第8章半月軟骨修復錨釘市場（按類型分類）

  • 全部內容
  • 腦筋急轉彎
  • 由外向內
  • 經髕骨入路

第9章半月軟骨修復錨釘市場（依材料分類）

  • 生物可吸收聚合物
  • 鈦

第10章半月軟骨修復錨釘市場（按應用領域分類）

  • 關節鏡
  • 開放性手術

第11章半月軟骨修復錨釘市場（按最終用戶分類）

  • 門診手術中心
  • 醫院
  • 專科診所

第12章 各地區半月軟骨修復錨釘市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章半月軟骨修復錨釘市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國半月軟骨修復錨定市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國半月軟骨修復錨釘市場

第17章 中國半月軟骨修復錨釘市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Aesculap Implant Systems GmbH
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • Biosuture Inc.
  • CONMED Corporation
  • ConMed Linvatec
  • DJO Global, Inc.
  • Exactech, Inc.
  • Globus Medical, Inc.
  • Heraeus Medical GmbH
  • Integra LifeSciences Holdings Corporation
  • Medtronic plc
  • Neoligaments Ltd.
  • Olympus Corporation
  • Orthomed Medical Ltd.
  • OrthoSpace Ltd.
  • Parcus Medical, LLC
  • Smith & Nephew Orthopaedics Ltd.
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-0A380695185D

The Meniscus Repair Anchor Market was valued at USD 558.12 million in 2025 and is projected to grow to USD 603.16 million in 2026, with a CAGR of 7.34%, reaching USD 916.37 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 558.12 million
Estimated Year [2026] USD 603.16 million
Forecast Year [2032] USD 916.37 million
CAGR (%) 7.34%

Introduction framing the clinical priorities, procedural efficiencies, and commercial pressures that are reshaping meniscus repair anchor development and adoption

The landscape for meniscus repair anchors is undergoing a period of disciplined innovation driven by clinical evidence, surgical technique evolution, and shifting healthcare delivery channels. Devices designed to restore knee stability and function are increasingly evaluated not only on fixation strength and biocompatibility but also on how they integrate with arthroscopic workflows, instrumentation ergonomics, and cost-conscious care pathways. Surgeons and purchasing stakeholders alike are prioritizing solutions that offer reliable clinical outcomes while streamlining operating room time and inventory complexity.

This introduction establishes the foundational context for subsequent analysis by highlighting the confluence of clinical imperatives and commercial pressures. The growing preference for minimally invasive arthroscopic procedures, the maturation of bioabsorbable materials, and the heightened scrutiny of total episode costs collectively define the decision criteria that manufacturers, payers, and providers must navigate. Transitioning from traditional open techniques to refined arthroscopic approaches has magnified the importance of anchor design, delivery systems, and surgeon training programs. As stakeholders seek to balance clinical efficacy with procedural efficiency, strategic choices across product development, market access, and post-market evidence generation will determine which technologies achieve sustained adoption.

How clinical technique evolution, materials innovation, and value-driven care delivery are converging to transform meniscus repair anchor strategy and market dynamics

Recent years have witnessed transformative shifts across clinical practice, materials science, and care delivery that are redefining the meniscus repair anchor landscape. Minimally invasive arthroscopic techniques have continued to expand as training programs and device innovators reduce intraoperative complexity, enabling more consistent repair of complex tear patterns and extending indications to broader patient cohorts. Parallel advances in anchor geometries and delivery systems have improved handling characteristics, while the refinement of bioabsorbable polymers has accelerated surgeon confidence in long-term tissue integration without permanent hardware burden.

Concurrently, procedural migration toward ambulatory settings has placed a premium on implants that reduce operating room time and simplify inventory management. Payers and provider networks are pursuing value-based arrangements that reward durable clinical outcomes and cost containment, prompting manufacturers to align clinical evidence generation with health economics narratives. Supply chain resilience has also emerged as a competitive differentiator, with companies investing in diversified sourcing strategies and production agility. Taken together, these shifts favor manufacturers that can couple robust clinical data with pragmatic device design, scalable manufacturing, and responsive commercial models that meet the practical needs of surgeons and healthcare systems.

Assessment of how tariff-driven supply chain shifts and trade policy adjustments in 2025 have influenced procurement behavior, sourcing strategy, and cost pressures across the device value chain

The imposition of tariffs and trade policy changes in recent policy cycles has had a cascading effect across medical device procurement, component sourcing, and pricing dynamics, creating a material context for strategic planning in 2025 and beyond. Tariffs that affect raw materials, finished goods, and intermediate components have raised landed costs for many device manufacturers, compelling reviews of supplier contracts, alternative sourcing geographies, and price negotiations with institutional purchasers. These cost pressures have prompted procurement teams to scrutinize total cost of ownership more closely, including device durability, reoperation rates, and operational efficiency that influence episode-of-care economics.

In response to tariff-driven inflationary pressures, several manufacturers accelerated supply chain reconfiguration efforts that prioritize nearshoring and multi-sourcing strategies. This has led to selective onshoring of critical production steps and investments in local inventory buffers to protect against volatility. Payers and health systems, meanwhile, have intensified demand for demonstrable value, placing performance and cost-effectiveness at the center of purchasing decisions. For clinical leaders, the practical consequence is a heightened emphasis on evidence that connects anchor choice with measurable improvements in procedural efficiency and patient outcomes, enabling stakeholders to justify premium pricing where clinical and economic benefits are substantiated.

Detailed segmentation insights that explain how device type, material selection, clinical approach, and end-user environment jointly shape adoption patterns and commercial positioning

Segmentation-driven insights reveal differentiated adoption and development trajectories across device types, materials, clinical indications, and care settings. Analysis across All-Inside, Inside-Out, Outside-In, and Trans-Patellar repair techniques shows that devices optimized for minimally invasive arthroscopic workflows are capturing increased clinician preference where visualization and soft-tissue handling are critical. Design choices that reduce knot tying, simplify passage, and shorten operative time are particularly valued in settings with high procedural throughput.

Material selection between bioabsorbable polymer and titanium anchors remains a pivotal factor influencing clinical choice and product positioning. Bioabsorbable polymer technologies appeal to stakeholders focused on long-term tissue remodeling and minimizing permanent hardware, while titanium anchors retain strength and predictable fixation, especially in complex repairs or patients with higher biomechanical demands. Application context, whether arthroscopic or open, drives product configuration and instrumentation needs; arthroscopic applications prioritize low-profile delivery and modular instrumentation, whereas open repairs emphasize robust fixation options and straightforward implantation.

End user dynamics across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics further modulate purchasing behaviors and implementation timelines. Ambulatory settings prioritize cost-efficiency and devices that streamline turnover, hospitals emphasize comprehensive clinical evidence and multi-disciplinary procurement processes, and specialty clinics focus on patient throughput and surgeon preference continuity. Together, these segmentation layers inform how manufacturers should tailor evidence generation, commercial models, and training programs to address distinct clinical workflows and procurement criteria.

Comparative regional analysis describing how clinical practice, reimbursement complexity, and supply chain considerations influence product adoption across global markets

Regional dynamics exhibit meaningful variance in clinical practice patterns, reimbursement frameworks, and supply chain logistics that influence product strategies and commercialization plans. In the Americas, strong institutional adoption of minimally invasive techniques and a concentrated network of ambulatory centers create fertile opportunities for devices that demonstrate clear procedural efficiency and durable outcomes. Payor negotiations and hospital procurement processes in this region emphasize comparative clinical evidence and lifecycle cost considerations as key determinants of adoption.

Europe, Middle East & Africa presents a fragmented regulatory and reimbursement landscape with a blend of centralized and localized purchasing behaviors. Clinical practice in many countries within this region emphasizes long-term outcomes and cost-effectiveness, which elevates the importance of robust clinical registries and multi-center evidence. Supply chain complexity and variable import duties across jurisdictions necessitate adaptable distribution strategies and local partnerships to ensure timely access.

Asia-Pacific is characterized by rapid surgical volume growth, expanding hospital infrastructure, and an increasing number of ambulatory facilities. Manufacturers that invest in surgeon education, local clinical data generation, and flexible pricing structures can accelerate uptake. Across all regions, resilience in logistics, responsiveness to regulatory variations, and the capacity to support post-market surveillance are central to sustained commercial success.

Key competitive dynamics and company-level strategies that reveal how product design, clinical evidence, and supply chain resilience determine market positioning

Competitive dynamics in the meniscus anchor domain are shaped by a blend of legacy orthopedic firms and agile specialty device companies that differentiate through materials science, instrumentation design, and surgeon education programs. Established manufacturers often leverage extensive distribution networks and clinical evidence portfolios to maintain preferential access in hospital systems and large purchasing groups, while smaller innovators tend to compete on novel delivery mechanisms, simplified surgical workflows, and targeted clinical data that demonstrate niche advantages.

Strategic partnerships between clinical centers of excellence and manufacturers have become a focal point for accelerating evidence generation and surgeon adoption. Companies that invest in high-quality post-market surveillance, registry data, and peer-to-peer training programs strengthen clinician confidence and facilitate guideline inclusion. At the same time, supply chain capabilities, including contract manufacturing agility and inventory management, are critical differentiators given recent disruptions and tariff-related cost pressures. Intellectual property around anchor geometry, fixation chemistry, and deployment systems continues to influence competitive positioning, and firms that align product design with real-world efficiency metrics are more likely to secure favorable procurement outcomes.

Actionable recommendations for manufacturers and provider leaders to align clinical evidence, supply chain strategy, and commercial models for sustained adoption and value delivery

Industry leaders should pursue an integrated approach that aligns product innovation with evidence generation, supply chain robustness, and tailored commercial models. Prioritize investment in clinical studies and registries that link anchor selection to meaningful patient-centered outcomes and procedure-level efficiencies, thereby enabling procurement and payer conversations that transcend unit price comparisons. Concurrently, streamline instrumentation to reduce operative steps and facilitate adoption among surgeons who balance speed and precision.

On the supply side, diversify sourcing and evaluate nearshoring opportunities to mitigate tariff and logistics risk while preserving cost competitiveness. Strengthen surgeon engagement through focused training programs and modular educational content that accelerates proficiency in contemporary arthroscopic techniques. Commercial teams should tailor pricing and contracting strategies to specific end-user environments, offering flexible bundles for ambulatory centers, integrated value propositions for hospital systems, and practice-level solutions for specialty clinics. Finally, integrate health economic modeling into pre-launch planning to articulate total episode benefits and to support premium positioning where justified by robust evidence.

Transparent explanation of the mixed-methods research approach combining clinician interviews, literature synthesis, and cross-stakeholder triangulation to validate insights

The research underpinning this analysis integrates primary qualitative interviews, secondary literature review, and a structured synthesis of clinical and procurement trends to build a coherent evidence narrative. Primary inputs included structured discussions with orthopedic surgeons, procurement leaders across ambulatory and hospital settings, and device development specialists to capture real-world use cases, adoption barriers, and clinical preferences. Secondary sources were drawn from peer-reviewed clinical studies, regulatory guidance, and public health policy documents to corroborate clinical performance and safety considerations.

Findings were validated through triangulation across multiple stakeholder perspectives to ensure balanced interpretation of clinical and commercial signals. The methodology prioritized transparency in data provenance, clear articulation of assumptions, and cross-validation of insights against observed adoption patterns and supply chain behaviors. Where necessary, sensitivity checks were performed to assess the robustness of conclusions against alternative interpretations of clinical practice evolution and procurement dynamics. This layered approach supports a pragmatic set of conclusions and recommendations that reflect both clinical realities and marketplace constraints.

Conclusion summarizing how evidence-driven product design, operational alignment, and resilient supply strategies together determine long-term adoption and commercial success

This analysis concludes that durable commercial success in the meniscus repair anchor space will favor solutions that integrate proven clinical performance with pragmatic considerations for procedure efficiency, supply chain resilience, and alignment to end-user operational needs. Device producers that emphasize evidence linking anchor selection to improved patient outcomes and reduced procedural burden will be best positioned to engage with value-focused purchasers and to withstand pricing pressures.

Moreover, the interplay of material selection, delivery system design, and targeted education will determine the pace and breadth of adoption across care settings. Manufacturers must balance innovation with pragmatic implementation strategies that reduce friction for surgeons and procurement teams. In short, the path to sustained adoption is paved by a combination of robust clinical data, thoughtful commercial models, and operational capabilities that ensure timely, cost-effective access for providers and patients alike.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Meniscus Repair Anchor Market, by Type

  • 8.1. All-Inside
  • 8.2. Inside-Out
  • 8.3. Outside-In
  • 8.4. Trans-Patellar

9. Meniscus Repair Anchor Market, by Material

  • 9.1. Bioabsorbable Polymer
  • 9.2. Titanium

10. Meniscus Repair Anchor Market, by Application

  • 10.1. Arthroscopic
  • 10.2. Open

11. Meniscus Repair Anchor Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Meniscus Repair Anchor Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Meniscus Repair Anchor Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Meniscus Repair Anchor Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Meniscus Repair Anchor Market

16. China Meniscus Repair Anchor Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Aesculap Implant Systems GmbH
  • 17.6. Arthrex, Inc.
  • 17.7. B. Braun Melsungen AG
  • 17.8. Biosuture Inc.
  • 17.9. CONMED Corporation
  • 17.10. ConMed Linvatec
  • 17.11. DJO Global, Inc.
  • 17.12. Exactech, Inc.
  • 17.13. Globus Medical, Inc.
  • 17.14. Heraeus Medical GmbH
  • 17.15. Integra LifeSciences Holdings Corporation
  • 17.16. Medtronic plc
  • 17.17. Neoligaments Ltd.
  • 17.18. Olympus Corporation
  • 17.19. Orthomed Medical Ltd.
  • 17.20. OrthoSpace Ltd.
  • 17.21. Parcus Medical, LLC
  • 17.22. Smith & Nephew Orthopaedics Ltd.
  • 17.23. Smith & Nephew plc
  • 17.24. Stryker Corporation
  • 17.25. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MENISCUS REPAIR ANCHOR MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MENISCUS REPAIR ANCHOR MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MENISCUS REPAIR ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MENISCUS REPAIR ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY ALL-INSIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY ALL-INSIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY ALL-INSIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY INSIDE-OUT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY INSIDE-OUT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY INSIDE-OUT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY OUTSIDE-IN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY OUTSIDE-IN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY OUTSIDE-IN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY TRANS-PATELLAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY TRANS-PATELLAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY TRANS-PATELLAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY BIOABSORBABLE POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY BIOABSORBABLE POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY BIOABSORBABLE POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY ARTHROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY ARTHROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY ARTHROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. AMERICAS MENISCUS REPAIR ANCHOR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 41. AMERICAS MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 45. NORTH AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. NORTH AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. LATIN AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. LATIN AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. LATIN AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. MIDDLE EAST MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. MIDDLE EAST MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. MIDDLE EAST MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 68. MIDDLE EAST MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. MIDDLE EAST MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 73. AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. AFRICA MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. ASEAN MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. ASEAN MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. ASEAN MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. ASEAN MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. ASEAN MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GCC MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GCC MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. GCC MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 89. GCC MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. GCC MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPEAN UNION MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPEAN UNION MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPEAN UNION MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPEAN UNION MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPEAN UNION MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. BRICS MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. BRICS MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. BRICS MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. BRICS MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. BRICS MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. G7 MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. G7 MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. G7 MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 104. G7 MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. G7 MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NATO MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NATO MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NATO MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. NATO MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. NATO MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MENISCUS REPAIR ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. UNITED STATES MENISCUS REPAIR ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. UNITED STATES MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. UNITED STATES MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 115. UNITED STATES MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. UNITED STATES MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. CHINA MENISCUS REPAIR ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. CHINA MENISCUS REPAIR ANCHOR MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. CHINA MENISCUS REPAIR ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. CHINA MENISCUS REPAIR ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. CHINA MENISCUS REPAIR ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)